Schrödinger (NASDAQ:SDGR) Shares Gap Up – Should You Buy?

Schrödinger, Inc. (NASDAQ:SDGR) shares gapped up before the market opened on Tuesday . The stock had previously closed at $24.85, but opened at $26.11. Schrödinger shares last traded at $28.18, with a volume of 616,859 shares changing hands.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on SDGR shares. BMO Capital Markets boosted their target price on shares of Schrödinger from $25.00 to $28.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. KeyCorp lifted their price target on shares of Schrödinger from $25.00 to $27.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Three research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Schrödinger has an average rating of “Moderate Buy” and an average target price of $32.11.

Schrödinger Stock Down 7.7 %

The stock’s 50 day moving average is $22.10 and its 200-day moving average is $20.44. The company has a market cap of $1.75 billion, a PE ratio of -10.26 and a beta of 1.61.

Institutional Trading of Schrödinger

Several hedge funds have recently made changes to their positions in the business. Two Sigma Advisers LP bought a new stake in Schrödinger during the fourth quarter worth approximately $473,000. Two Sigma Investments LP purchased a new position in shares of Schrödinger in the 4th quarter worth approximately $1,939,000. Tema Etfs LLC bought a new position in shares of Schrödinger during the 4th quarter valued at approximately $671,000. Point72 Hong Kong Ltd bought a new position in shares of Schrödinger during the 4th quarter valued at approximately $27,000. Finally, ProShare Advisors LLC raised its holdings in Schrödinger by 44.5% during the 4th quarter. ProShare Advisors LLC now owns 16,754 shares of the company’s stock valued at $323,000 after buying an additional 5,158 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.